Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaRCUS: Palliative Chemo-Radiotherapy in Non-Curative Esophageal Cancer
NCT02297217Phase 2Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Nov 2019
- Primary completion
- Apr 2027
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection in esophageal cancer, sponsored by American Health Staffing Group. Started Nov 2019; status: recruiting.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02297217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297217.